Augmentin '125' and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Meropenem (meropenem). Common drug interactions include dermatitis among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Meropenem. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 16, 2026

21 people who take Augmentin '125' and Meropenem together, and have interactions are studied.

Augmentin '125' and Meropenem drug interactions.

What are the common drug interactions of Augmentin '125' and Meropenem, by gender? *:

female:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  5. Acute circulatory failure (shock)
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Blood albumin decreased
  8. Cardiac failure
  9. Constipation
  10. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  3. Blood bilirubin increased
  4. Blood calcium decreased
  5. Blood creatine phosphokinase decreased
  6. Blood creatinine increased
  7. Blood urea increased
  8. C-reactive protein increased
  9. Gamma-glutamyltransferase increased
  10. Glomerular filtration rate decreased

What are the common drug interactions of Augmentin '125' and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Drug resistance (reduction in effectiveness of a drug)
  2. Petechiae (a small red or purple spot caused by bleeding into the skin)

10-19:

  1. Rash

20-29:

n/a

30-39:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  3. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  4. Acute circulatory failure (shock)
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Blood albumin decreased
  7. Cardiac failure
  8. Constipation
  9. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  10. Diarrhoea

40-49:

  1. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  2. Hyperpyrexia (extremely high fever)

50-59:

n/a

60+:

  1. Cardiac arrest
  2. Death
  3. Aspergillosis (an infection caused by a fungus called aspergillus)
  4. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Leukopenia (less number of white blood cells in blood)
  7. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  8. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

What are the existing conditions these people have? *

  1. Pneumonia: 2 people, 9.52%
  2. Hepatic Neoplasm Malignant (liver cancer): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and meropenem (the active ingredients of Augmentin '125' and Meropenem, respectively), and Augmentin '125' and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: